• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Hadera Paper

Hadera Paper

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. Alnylam Reports Positive Initial Clinical Activity Results for Givosiran (ALN-AS1), an Investigational RNAi Therapeutic for the Treatment of Acute Hepatic Porphyrias

    Alnylam Reports Positive Initial Clinical Activity Results for Givosiran (ALN-AS1), an Investigational RNAi Therapeutic for the Treatment of Acute Hepatic Porphyrias

  2. Morgan Stanley Unit Launches Alt Fund

    Morgan Stanley Alternative Investment Partners announced the launch of the AIP Dynamic Alternative Strategies Fund, its first mutual fund.

  3. How Dollar-Cost Averaging Can Smooth Your Returns

    This tried-and-true investment method helps investors navigate volatile markets.

  4. How Dollar-Cost Averaging Can Smooth Your Returns

    This tried-and-true investment method helps investors navigate volatile markets.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.